The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Gout and the risk of acute myocardial infarction
Abstract
Objective: To determine if hyperuricemia and gouty arthritis are independent risk factors for acute myocardial infarction (MI) and, if so, whether they are independent of renal function, diuretic use, metabolic syndrome, and other established risk factors. Methods: We performed multivariable logistic and instrumental variable probit regressions on data from the Multiple Risk Factor Intervention Trial (MRFIT). Results: Overall, there were 12,866 men in the MRFIT who were followed up for a mean of 6.5 years. There were 118 events of acute MI in the group with gout (10.5%) and 990 events in the group without gout (8.43%; P = 0.018). Hyperuricemia was an independent risk factor for acute MI in the multivariable regression models, with an odds ratio (OR) of 1.11 (95% confidence interval [95% CI] 1.08–1.15, P < 0.001). In multivariable regressions in which the above risk factors were used as covariates, gout was found to be associated with a higher risk of acute MI (OR 1.26 [95% CI 1.14–1.40], P < 0.001). Subgroup analyses showed that a relationship between gout and the risk of acute MI was present among nonusers of alcohol, diuretics, or aspirin and among those who did not have metabolic syndrome, diabetes mellitus, or obesity. In separate analyses, a relationship between gout and the risk of acute MI was evident among those with and without those hyperuricemia. Conclusion: The independent risk relationship between hyperuricemia and acute MI is confirmed. Gouty arthritis is associated with an excess risk of acute MI, and this is not explained by its well‐known links with renal function, metabolic syndrome, diuretic use, and traditional cardiovascular risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D., Kupersmith, J., Levin, T. N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1193 · Cited by 4,487
Preliminary criteria for the classification of the acute arthritis of primary gout
Wallace, S. L., Robinson, H., Masi, A. T., Decker, J. L., Mccarty, D. J., & Yü, T. (1977) · Arthritis & Rheumatism · doi:10.1002/art.1780200320 · Cited by 1,432
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
Becker, M. A., Schumacher, H. R., Wortmann, R. L., MacDonald, P. A., Eustace, D., Palo, W. A., Streit, J., & Joseph-Ridge, N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050373 · Cited by 1,357
Self-citationBraunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D., Kupersmith, J., Levin, T. N., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00889-5 · Cited by 963
Choi, H. K., Mount, D. B., & Reginato, A. M. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-7-200510040-00009 · Cited by 942
Inflammation and Coronary Artery Disease
Alexander, R. W. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310709 · Cited by 400
Gout and coronary heart disease: The framingham study
Abbott, R. D., Brand, F. N., Kannel, W. B., & Castelli, W. P. (1988) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(88)90127-8 · Cited by 355
Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us?
Baker, J. F., Krishnan, E., Chen, L., & Schumacher, H. R. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.03.043 · Cited by 354
Self-citationRheumatoid Arthritis: A Disease Associated with Accelerated Atherogenesis
Gonzalez-Gay, M. A., Gonzalez-Juanatey, C., & Martin, J. (2005) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2005.03.004 · Cited by 331
Alcohol and mortality: a review of prospective studies
SHAPER, A. G. (1990) · British Journal of Addiction · doi:10.1111/j.1360-0443.1990.tb03710.x · Cited by 296
Cited by
Zhu, Y., Pandya, B. J., & Choi, H. K. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30520 · Cited by 1,785
2016 updated EULAR evidence-based recommendations for the management of gout
Richette, P., Doherty, M., Pascual, E., Barskova, V, Becce, F., Castañeda-Sanabria, J., Coyfish, M., Guillo, S., Jansen, T. L., Janssens, H., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209707 · Cited by 1,681
Khanna, D., Fitzgerald, J. D., Khanna, P. P., Bae, S., Singh, M. K., Neogi, T., Pillinger, M. H., Merill, J., Lee, S., Prakash, S., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21772 · Cited by 1,536
Self-citationGlobal epidemiology of gout: prevalence, incidence and risk factors
Kuo, C.-F., Grainge, M. J., Zhang, W., & Doherty, M. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.91 · Cited by 1,179
Richette, P., & Bardin, T. (2010) · The Lancet · doi:10.1016/s0140-6736(09)60883-7 · Cited by 915
Hyperuricemia and coronary heart disease: A systematic review and meta‐analysis
Kim, S. Y., Guevara, J. P., Kim, K. M., Choi, H. K., Heitjan, D. F., & Albert, D. A. (2010) · Arthritis Care & Research · doi:10.1002/acr.20065 · Cited by 671
Independent Impact of Gout on Mortality and Risk for Coronary Heart Disease
Choi, H. K., & Curhan, G. (2007) · Circulation · doi:10.1161/circulationaha.107.703389 · Cited by 666
Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study
Kuo, C.-F., Grainge, M. J., Mallen, C., Zhang, W., & Doherty, M. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204463 · Cited by 622
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005
Annemans, L., Spaepen, E., Gaskin, M., Bonnemaire, M., Malier, V, Gilbert, T., & Nuki, G. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.076232 · Cited by 495
Serum uric acid and the risk of cardiovascular and renal disease
Borghi, C., Rosei, E. A., Bardin, T., Dawson, J., Dominiczak, A., Kielstein, J. T., Manolis, A. J., Perez-Ruiz, F., & Mancia, G. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000701 · Cited by 463
Mechanism of Action of Colchicine in the Treatment of Gout
Dalbeth, N., Lauterio, T. J., & Wolfe, H. R. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.07.017 · Cited by 416
Uric acid, hyperuricemia and vascular diseases
Jin, M. (2012) · Frontiers in Bioscience · doi:10.2741/3950 · Cited by 406
Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options
Bardin, T., & Richette, P. (2017) · BMC Medicine · doi:10.1186/s12916-017-0890-9 · Cited by 385
Uric acid: A marker of increased cardiovascular risk
Gagliardi, A. C. M., Miname, M. H., & Santos, R. D. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.05.022 · Cited by 384
Chen, J., Chuang, S., Chen, H., Yeh, W., & Pan, W. (2009) · Arthritis Care & Research · doi:10.1002/art.24164 · Cited by 375
Roddy, E., & Doherty, M. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3199 · Cited by 370
Long-term Cardiovascular Mortality Among Middle-aged Men With Gout
Krishnan, E. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.10.1104 · Cited by 328
Self-citationFructose-Rich Beverages and Risk of Gout in Women
Choi, H. K., Willett, W., & Curhan, G. (2010) · JAMA · doi:10.1001/jama.2010.1638 · Cited by 314
Janssens, H. J., Janssen, M., van de Lisdonk, E. H., van Riel, P. L., & van Weel, C. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60799-0 · Cited by 317
PEG-uricase in the management of treatment-resistant gout and hyperuricemia
Sherman, M. R., Saifer, M. G. P., & Perez-Ruiz, F. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.011 · Cited by 291
Urate‐induced immune programming: Consequences for gouty arthritis and hyperuricemia
Cabău, G., Crișan, T. O., Klück, V., Popp, R. A., & Joosten, L. A. B. (2020) · Immunological Reviews · doi:10.1111/imr.12833 · Cited by 261
Li, M., Hu, X., Fan, Y., Li, K., Zhang, X., Hou, W., & Tang, Z. (2016) · Scientific Reports · doi:10.1038/srep19520 · Cited by 257
Analysis of Oral Microbiota Revealed High Abundance of Prevotella Intermedia in Gout Patients
Liu, J., Cui, L., Yan, X., Zhao, X., Cheng, J., Zhou, L., Gao, J., Cao, Z., Ye, X., & Hu, S. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000493626 · Cited by 45
Metadata
- Authors
- Krishnan, E., Baker, J. F., Furst, D. E., & Schumacher, H. R.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2006-07-26
- Volume
- 54
- Issue
- 8
- Pages
- 2688-2696
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1963805301
- Cited by
- 430
- References
- 29
- FWCI
- 13.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.